4.0
Apr 13, 2018
Anonymous employee
Current employee, more than 3 years
Cambridge, MA
Recommend
CEO approval
Business Outlook
Pros
A good size biotech company with a rich Oncology pipeline. Stocks are doing very well.
Cons
Sometimes the company does not appreciate the good job done.